• 1. The Third Clinical Medical College, Fujian Medical University, Fuzhou, Fujian 350000, P. R. China;
  • 2. School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350000, P. R. China;
  • 3. Fujian Key Laboratory of Natural Medicine Pharmacology, Fuzhou, Fujian 350000, P. R. China;
YANG Jian, Email: fjmukent@mail.fjmu.edu.cn
Export PDF Favorites Scan Get Citation

Rheumatoid arthritis (RA) is a chronic autoimmune disease remarkably characterized by synovitis of joints, whose pathogenesis is complicated and not yet fully elucidated. A variety of cells, cytokines and intercellular signaling pathways are involved in the occurrence and development of RA. The mitogen activation protein kinase (MAPK) signaling pathway is closely related to the pathogenesis of RA, and plays an important role in the formation of pannus, synovitis, and bone destruction. This paper reviews the research progress of MAPK signaling pathway in RA from the aspects of the interaction of MAPK signaling pathway with a variety of key cells and cytokines in the pathogenesis of RA, in order to provide a direction and theoretical basis for anti-RA drug therapy research.

Citation: XIAO Zhuoran, ZHANG Haiping, HE Yufang, PAN Xuan, ZHENG Enping, CHEN Bing, YU Changxi, YANG Jian. Research progress of mitogen activation protein kinase signaling pathway in rheumatoid arthritis. West China Medical Journal, 2022, 37(3): 453-459. doi: 10.7507/1002-0179.202011092 Copy

  • Previous Article

    Cells respond to mechanical stress and corresponding mechanisms of signal transduction
  • Next Article

    Research progress of adenosine activated protein kinase α1 in tumor